News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The ASCO Ed Book is seeking an Editor-in-Chief
ASCO/X
Mar 12, 2025, 16:22

The ASCO Ed Book is seeking an Editor-in-Chief

American Society of Clinical Oncology (ASCO) shared a post on X:

“Want to shape the future of oncology news and education? The ASCO Ed Book is seeking an Editor-in-Chief to lead our team.

Apply now and make a difference.”

The ASCO Ed Book is seeking an Editor-in-Chief

More posts featuring ASCO.

American Society of Clinical Oncology ASCO ASCO Ed Book cancer OncoDaily Oncology
Special Coverage
Blog
May 4, 2025, 08:21
Hritika Deepak Pai received the MASCC 2025 Young Investigator Award
Insight
May 4, 2025, 07:39
Final Highlights from AACR Annual Meeting 2025 on Predictive Oncology and Lung Cancer Screening
Blog
May 4, 2025, 07:25
Fight Colorectal Cancer Urges Action Against President's 2026 Budget Cuts
Oncolibrary
May 4, 2025, 07:25
Does Plastic Cause Cancer? Myths and Facts
Blog
May 4, 2025, 07:01
UICC Highlights Study Linking Cancer and Higher Risk of Drug-Resistant Infections
Societies
May 4, 2025, 06:43
STAR-TREC Study Shows successful Organ Preservation with Chemoradiotherapy or Short-Course Radiotherapy, Reducing the Need for Surgery in Early-Intermediate Stage Rectal Cancer Patients
Blog
May 4, 2025, 06:41
Peter Pisters: Pleased to start the day at MD Anderson Cancer Center's Research Town Hall for AACR25
Blog
May 4, 2025, 06:36
Ahmed Magdy Rabea: Pleasure to join my friend Amr Shafik at CAIRO Journal Club – Lung 360 meeting
Blog
May 4, 2025, 06:30
Medicaid Cancer Foundation participated in the official opening of the Nigerian Cancer Society Secretariat
Science
May 4, 2025, 06:29
Preferred Paper at ESTRO 2025: risk factors for acute gastrointestinal (GI) toxicity during EBRT and concurrent chemotherapy in LACC
Blog
May 4, 2025, 06:11
Zhen Su: The era of Immun-oncology 2.0 is here
Societies
May 4, 2025, 05:42
PRIME-RT a randomized phase Il trial: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC)